Research & Development

The Research & Development (R&D) Center of Fresenius Kabi Oncology Limited operates out of a highly modern facility based in Gurgaon, India and is engaged in developing next-generation cytotoxic, cytostatic along with therapies in other therapeutic areas. It delivers high-quality and cost-effective products using cutting-edge technology while following the highest quality standards for all its products, irrespective of the target market. The R&D Centre is ideally equipped to develop a wide range of medicinal products through its modern chemistry, formulation and analytical laboratories, which have the capability to handle a wide range of products and develop processes that are safe, cost-effective, non-infringing and scalable to the plant level with minimal rework.

Fresenius Kabi Oncology Limited possess a broad portfolio of oncology and other generic products with an emphasis on “First to Market” opportunities. The Company’s innovative product offering reflects its capabilities in innovation & development. The project management-based strategy adopted in product development section enables a streamlined process and delivery.

Fresenius Kabi Oncology Limited’s research and development focus has enabled it to continually move up the growth ladder. Enabled by continuous expansion and strengthening of the R&D facilities over the years, the R&D Centre has emerged as a global center of excellence in oncology and other therapeutic areas for the development of API and finished dosage forms.

Focus Areas

●     API Development

●     Formulation Development

●     Analytical Development

●     Regulatory Affairs

●     Intellectual Property Management

●     Project Management

●     Quality Assurance

●     Clinical Trials and Research

●     Global Vigilance Center